Data:
{
"symbol": "AMLX",
"price": 35.63,
"marketCap": 3961568582,
"beta": -0.205,
"lastDividend": 1.02,
"range": "7.82-37.11",
"change": 0.52,
"changePercentage": 1.48106,
"volume": 1552858,
"averageVolume": 1748572,
"companyName": "Amylyx Pharmaceuticals, Inc.",
"currency": "USD",
"cik": "0001658551",
"isin": "US03237H1014",
"cusip": "03237H101",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://amylyx.com",
"description": "Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.",
"ceo": "Joshua Cohen",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "136",
"phone": "617 682 0917",
"address": "55 Cambridge Parkway",
"city": "Cambridge",
"state": "MA",
"zip": "02142",
"image": "https://images.financialmodelingprep.com/symbol/AMLX.png",
"ipoDate": "2022-01-07",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "AMLX",
"name": "Amylyx Pharmaceuticals, Inc.",
"price": 35.63,
"changePercentage": 1.48106,
"change": 0.52,
"volume": 1552747,
"dayLow": 35.3207,
"dayHigh": 37.11,
"yearHigh": 37.11,
"yearLow": 7.82,
"marketCap": 3961568582,
"priceAvg50": 18.729,
"priceAvg200": 15.35835,
"exchange": "NASDAQ",
"open": 36.11,
"previousClose": 35.11,
"timestamp": 1787147335,
"chart_vwap_daily": [
{
"t": "2026-07-09",
"v": 18.3558,
"c": 18.38
},
{
"t": "2026-07-10",
"v": 17.6613,
"c": 17.77
},
{
"t": "2026-07-13",
"v": 17.2929,
"c": 17.41
},
{
"t": "2026-07-14",
"v": 18.1532,
"c": 18.2
},
{
"t": "2026-07-15",
"v": 17.6723,
"c": 17.78
},
{
"t": "2026-07-16",
"v": 17.172,
"c": 17.02
},
{
"t": "2026-07-17",
"v": 17.7329,
"c": 17.75
},
{
"t": "2026-07-20",
"v": 17.674,
"c": 17.45
},
{
"t": "2026-07-21",
"v": 18.4346,
"c": 18.5
},
{
"t": "2026-07-22",
"v": 17.8933,
"c": 17.7
},
{
"t": "2026-07-23",
"v": 17.7407,
"c": 17.59
},
{
"t": "2026-07-24",
"v": 18.0167,
"c": 18.41
},
{
"t": "2026-07-27",
"v": 18.8712,
"c": 19.49
},
{
"t": "2026-07-28",
"v": 19.4917,
"c": 19.55
},
{
"t": "2026-07-29",
"v": 19.7064,
"c": 19.73
},
{
"t": "2026-07-30",
"v": 20.0936,
"c": 20.75
},
{
"t": "2026-07-31",
"v": 20.0538,
"c": 20.31
},
{
"t": "2026-08-03",
"v": 20.0377,
"c": 20.17
},
{
"t": "2026-08-04",
"v": 21.7486,
"c": 21.87
},
{
"t": "2026-08-05",
"v": 21.8378,
"c": 21.85
},
{
"t": "2026-08-06",
"v": 23.8115,
"c": 24.19
},
{
"t": "2026-08-07",
"v": 23.0828,
"c": 22.82
},
{
"t": "2026-08-10",
"v": 22.4546,
"c": 22.67
},
{
"t": "2026-08-11",
"v": 23.4872,
"c": 23.63
},
{
"t": "2026-08-12",
"v": 23.6636,
"c": 23.35
},
{
"t": "2026-08-13",
"v": 22.8499,
"c": 22.48
},
{
"t": "2026-08-14",
"v": 21.6285,
"c": 21.63
},
{
"t": "2026-08-17",
"v": 22.3694,
"c": 21.43
},
{
"t": "2026-08-18",
"v": 31.4447,
"c": 35.11
},
{
"t": "2026-08-19",
"v": 36.2896,
"c": 35.37
}
],
"vwap_summary": {
"days": 30,
"days_above": 21,
"days_below": 9,
"pct_days_above": 70,
"position": "below",
"gap_pct": -2.53,
"streak_days": 1
}
}
Data:
{
"volume": 1552747,
"avgVolume": 1748572,
"short_ratio": [
{
"symbol": "AMLX",
"file_date": "2026-08-18",
"date": "20260818",
"short_volume": 5081877,
"short_exempt_volume": 37019,
"total_volume": 10212316,
"short_volume_ratio": 0.4976,
"signal": "Neutral"
}
],
"volume_profile": {
"poc": 19.35,
"vah": 31.08,
"val": 17.26,
"profile": [
{
"price": 17.42,
"volume": 217076
},
{
"price": 17.74,
"volume": 874977
},
{
"price": 18.06,
"volume": 717261
},
{
"price": 18.38,
"volume": 881293
},
{
"price": 18.71,
"volume": 416698
},
{
"price": 19.03,
"volume": 1019270
},
{
"price": 19.35,
"volume": 3283984
},
{
"price": 19.67,
"volume": 2998358
},
{
"price": 19.99,
"volume": 1964083
},
{
"price": 20.31,
"volume": 1751819
},
{
"price": 20.63,
"volume": 327323
},
{
"price": 20.96,
"volume": 603562
},
{
"price": 21.28,
"volume": 660702
},
{
"price": 21.6,
"volume": 2203568
},
{
"price": 21.92,
"volume": 2872840
},
{
"price": 22.24,
"volume": 1188484
},
{
"price": 22.56,
"volume": 787197
},
{
"price": 22.88,
"volume": 2226332
},
{
"price": 23.21,
"volume": 942128
},
{
"price": 23.53,
"volume": 1641719
},
{
"price": 23.85,
"volume": 1943380
},
{
"price": 24.17,
"volume": 1123756
},
{
"price": 24.49,
"volume": 46655
},
{
"price": 24.81,
"volume": 0
},
{
"price": 25.13,
"volume": 0
},
{
"price": 25.45,
"volume": 0
},
{
"price": 25.78,
"volume": 0
},
{
"price": 26.1,
"volume": 0
},
{
"price": 26.42,
"volume": 0
},
{
"price": 26.74,
"volume": 0
},
{
"price": 27.06,
"volume": 0
},
{
"price": 27.38,
"volume": 0
},
{
"price": 27.7,
"volume": 0
},
{
"price": 28.03,
"volume": 0
},
{
"price": 28.35,
"volume": 0
},
{
"price": 28.67,
"volume": 1345129
},
{
"price": 28.99,
"volume": 0
},
{
"price": 29.31,
"volume": 871744
},
{
"price": 29.63,
"volume": 546369
},
{
"price": 29.95,
"volume": 1372429
},
{
"price": 30.28,
"volume": 0
},
{
"price": 30.6,
"volume": 0
},
{
"price": 30.92,
"volume": 1574771
},
{
"price": 31.24,
"volume": 2649353
},
{
"price": 31.56,
"volume": 166761
},
{
"price": 31.88,
"volume": 1327437
},
{
"price": 32.2,
"volume": 908642
},
{
"price": 32.52,
"volume": 1318522
},
{
"price": 32.85,
"volume": 562082
},
{
"price": 33.17,
"volume": 1485512
},
{
"price": 33.49,
"volume": 1067851
},
{
"price": 33.81,
"volume": 878820
},
{
"price": 34.13,
"volume": 0
},
{
"price": 34.45,
"volume": 230567
},
{
"price": 34.77,
"volume": 585685
},
{
"price": 35.1,
"volume": 1947960
},
{
"price": 35.42,
"volume": 0
},
{
"price": 35.74,
"volume": 172618
},
{
"price": 36.06,
"volume": 428818
},
{
"price": 36.38,
"volume": 606589
}
],
"sessions": 20
}
}
Data:
{
"symbol": "AMLX",
"marketCap": 3969351709,
"enterpriseValueTTM": 3925280624,
"evToSalesTTM": 0,
"evToOperatingCashFlowTTM": -31.011010760248702,
"evToFreeCashFlowTTM": -30.976749047089182,
"evToEBITDATTM": -26.206799987982453,
"netDebtToEBITDATTM": 0.2942362515939939,
"currentRatioTTM": 12.12,
"incomeQualityTTM": 0.8322396970254846,
"grahamNumberTTM": null,
"grahamNetNetTTM": 2.0267024930905664,
"taxBurdenTTM": 1.0003025400207832,
"interestBurdenTTM": 1.0126273726273727,
"workingCapitalTTM": 235188000,
"investedCapitalTTM": 239928000,
"returnOnAssetsTTM": -0.5748779123387914,
"operatingReturnOnAssetsTTM": -0.5808440842973519,
"returnOnTangibleAssetsTTM": -0.5748779123387914,
"returnOnEquityTTM": -0.5292075474324168,
"returnOnInvestedCapitalTTM": -0.6632136223416878,
"returnOnCapitalEmployedTTM": -0.6659600515993328,
"earningsYieldTTM": -0.03831294544510585,
"freeCashFlowYieldTTM": -0.03192385288325177,
"capexToOperatingCashFlowTTM": -0.0011060461221232925,
"capexToDepreciationTTM": 0.3794037940379404,
"capexToRevenueTTM": 0,
"salesGeneralAndAdministrativeToRevenueTTM": 0,
"researchAndDevelopementToRevenueTTM": 0,
"stockBasedCompensationToRevenueTTM": 0,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 50000,
"averagePayablesTTM": 4531000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 0,
"daysOfPayablesOutstandingTTM": 100.67020587209012,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 0,
"cashConversionCycleTTM": -100.67020587209012,
"freeCashFlowToEquityTTM": 60394000,
"freeCashFlowToFirmTTM": -130717000,
"tangibleAssetValueTTM": 239167000,
"netCurrentAssetValueTTM": 230941000,
"grossProfitMarginTTM": 0,
"ebitMarginTTM": 0,
"ebitdaMarginTTM": 0,
"operatingProfitMarginTTM": 0,
"pretaxProfitMarginTTM": 0,
"continuousOperationsProfitMarginTTM": 0,
"netProfitMarginTTM": 0,
"bottomLineProfitMarginTTM": 0,
"receivablesTurnoverTTM": 0,
"payablesTurnoverTTM": 3.6257003433941803,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 0,
"assetTurnoverTTM": 0,
"quickRatioTTM": 12.12,
"solvencyRatioTTM": -5.974052053392133,
"cashRatioTTM": 2.3321985815602835,
"priceToEarningsRatioTTM": -25.319148936170212,
"priceToEarningsGrowthRatioTTM": -0.4276873056815211,
"forwardPriceToEarningsGrowthRatioTTM": 3.2386034109216135,
"priceToEarningsDilutedRatioTTM": -25.319148936170212,
"priceToEarningsDilutedGrowthRatioTTM": -0.4276873056815211,
"priceToBookRatioTTM": 16.598145743769,
"priceToSalesRatioTTM": 0,
"priceToFreeCashFlowRatioTTM": -31.324539122611803,
"priceToOperatingCashFlowRatioTTM": -31.362164714758606,
"debtToAssetsRatioTTM": 0.019862868719856066,
"debtToEquityRatioTTM": 0.02197209481241141,
"debtToCapitalRatioTTM": 0.021499701336213598,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.1061893990391651,
"workingCapitalTurnoverRatioTTM": 0,
"operatingCashFlowRatioTTM": -5.984728132387707,
"operatingCashFlowSalesRatioTTM": 0,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0011060461221233,
"debtServiceCoverageRatioTTM": 0,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -24.08696479543292,
"capitalExpenditureCoverageRatioTTM": -904.1214285714286,
"dividendPaidAndCapexCoverageRatioTTM": -904.1214285714286,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0,
"netIncomePerShareTTM": -1.3677721523902788,
"interestDebtPerShareTTM": 0.04725851892808902,
"cashPerShareTTM": 2.2550991829510183,
"bookValuePerShareTTM": 2.150842663458471,
"tangibleBookValuePerShareTTM": 2.150842663458471,
"shareholdersEquityPerShareTTM": 2.150842663458471,
"operatingCashFlowPerShareTTM": -1.1383142817051806,
"capexPerShareTTM": 0.001259028097037576,
"freeCashFlowPerShareTTM": -1.139573309802218,
"netIncomePerEBTTTM": 1.0003025400207832,
"ebtPerEbitTTM": 0.9379534126239945,
"priceToFairValueTTM": 16.598145743769,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": -0.00030254002078318405,
"enterpriseValueMultipleTTM": -26.206799420487243,
"dividendPerShareTTM": 0,
"revenue_history": [],
"dcf": {
"symbol": "AMLX",
"date": "2026-08-18",
"dcf": 2.299318659074081,
"Stock Price": 33.17
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "AMLX",
"reportedCurrency": "USD",
"cik": "0001658551",
"filingDate": "2026-03-03",
"acceptedDate": "2026-03-03 07:10:58",
"fiscalYear": "2025",
"period": "FY",
"revenue": 0,
"costOfRevenue": 525000,
"grossProfit": -525000,
"researchAndDevelopmentExpenses": 90404000,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 62887000,
"otherExpenses": 0,
"operatingExpenses": 152766000,
"costAndExpenses": 153291000,
"netInterestIncome": 9302000,
"interestIncome": 9302000,
"interestExpense": 0,
"depreciationAndAmortization": 525000,
"ebitda": -144164000,
"ebit": -144689000,
"nonOperatingIncomeExcludingInterest": -8602000,
"operatingIncome": -153291000,
"totalOtherIncomeExpensesNet": 8602000,
"incomeBeforeTax": -144689000,
"incomeTaxExpense": 46000,
"netIncomeFromContinuingOperations": -144735000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -144735000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -144735000,
"eps": -1.53,
"epsDiluted": -1.53,
"weightedAverageShsOut": 94565567,
"weightedAverageShsOutDil": 94565567
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "AMLX",
"reportedCurrency": "USD",
"cik": "0001658551",
"filingDate": "2026-03-03",
"acceptedDate": "2026-03-03 07:10:58",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 226651000,
"shortTermInvestments": 90328000,
"cashAndShortTermInvestments": 316979000,
"netReceivables": 88000,
"accountsReceivables": 88000,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": 6604000,
"totalCurrentAssets": 323671000,
"propertyPlantEquipmentNet": 5491000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 3483000,
"totalNonCurrentAssets": 8974000,
"otherAssets": 0,
"totalAssets": 332645000,
"totalPayables": 3519000,
"accountPayables": 3519000,
"otherPayables": 0,
"accruedExpenses": 7855000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 1259000,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 10055000,
"totalCurrentLiabilities": 22688000,
"longTermDebt": 4698000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 0,
"totalNonCurrentLiabilities": 4698000,
"otherLiabilities": 0,
"capitalLeaseObligations": 1259000,
"totalLiabilities": 27386000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 11000,
"retainedEarnings": -751427000,
"additionalPaidInCapital": 1056271000,
"accumulatedOtherComprehensiveIncomeLoss": 404000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 305259000,
"totalEquity": 305259000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 332645000,
"totalInvestments": 90328000,
"totalDebt": 5957000,
"netDebt": -220694000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "AMLX",
"reportedCurrency": "USD",
"cik": "0001658551",
"filingDate": "2026-03-03",
"acceptedDate": "2026-03-03 07:10:58",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -144735000,
"depreciationAndAmortization": 525000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 27645000,
"changeInWorkingCapital": -1083000,
"accountsReceivables": 383000,
"inventory": 0,
"accountsPayables": 580000,
"otherWorkingCapital": -2046000,
"otherNonCashItems": -5695000,
"netCashProvidedByOperatingActivities": -123343000,
"investmentsInPropertyPlantAndEquipment": -138000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -231823000,
"salesMaturitiesOfInvestments": 246000000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": 14039000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 260390000,
"netCommonStockIssuance": 260390000,
"commonStockIssuance": 260390000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -3361000,
"netCashProvidedByFinancingActivities": 257029000,
"effectOfForexChangesOnCash": 1074000,
"netChangeInCash": 148799000,
"cashAtEndOfPeriod": 227636000,
"cashAtBeginningOfPeriod": 78837000,
"operatingCashFlow": -123343000,
"capitalExpenditure": -138000,
"freeCashFlow": -123481000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 37.03,
"rsi": 84.20145503364859,
"sma20": 22.703000000000003,
"sma50": 19.209400000000002,
"sma200": 15.473299999999988,
"adx": 48.581328929821105,
"atr": 2.41,
"atr_pct": 6.51,
"high_52w": 40.93,
"low_52w": 1.62,
"structure": {
"ema8": 27.67527987175552,
"ema21": 23.63070648265087,
"ema50": 20.349523472889224,
"ema200": 15.735608038512837,
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": true,
"higher_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": 56.7,
"macd": {
"macd": 3.112,
"signal": 1.851,
"histogram": 1.261
},
"bollinger": {
"mid": 22.7,
"upper": 32.26,
"lower": 13.15,
"width_pct": 84.18
},
"crossover": {
"fresh_cross": false,
"pre_compressed": false,
"held_above_21": false,
"candles_since": 45,
"intraday_support": false
},
"momentum": {
"roc10": 69.5,
"checks": {
"roc_over_5": true,
"rsi_in_band": false,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.36,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": true,
"surge_day": true,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 4.71,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": false,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 62301620.36000001,
"avg_vol": 1748572
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": true,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 0.5,
"iv_rank": 17.0
}
}
}
}
Data:
{
"prior_day": {
"high": 37.15,
"low": 35.32,
"close": 35.37,
"date": "2026-08-19"
},
"woodie_pivots": {
"PP": 35.8,
"R1": 36.28,
"S1": 34.46,
"R2": 37.63,
"S2": 33.97
},
"swing": {
"high_20d": 37.15,
"low_20d": 17,
"high_60d": 37.15,
"low_60d": 12.62
},
"orb": {
"high": 37.15,
"low": 35.32,
"date": "2026-08-19"
},
"vwap": 36.2,
"volume_profile": {
"poc": 19.35,
"vah": 31.08,
"val": 17.26,
"sessions": 20
},
"premarket": {
"date": "2026-08-19",
"high": 38.48,
"low": 34.85,
"last": 36.21,
"volume": 311726,
"gap_pct": 3.13,
"path": "04:00 35.05 -> 05:30 35.24 -> 07:30 36.75 -> 08:20 36.65 -> 09:10 36.50 -> 09:25 36.21",
"bars": 44,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-07-16",
"o": 17.75,
"h": 17.925,
"l": 16.8,
"c": 17.02,
"v": 941653.111081
},
{
"d": "2026-07-17",
"o": 16.7,
"h": 18.08,
"l": 16.52,
"c": 17.75,
"v": 1254027.287259
},
{
"d": "2026-07-20",
"o": 18,
"h": 18.53,
"l": 17.44,
"c": 17.45,
"v": 1414867.686499
},
{
"d": "2026-07-21",
"o": 17.44,
"h": 18.86,
"l": 17.38,
"c": 18.5,
"v": 2718878.951275
},
{
"d": "2026-07-22",
"o": 18.33,
"h": 18.65,
"l": 17.685,
"c": 17.7,
"v": 1562310.033438
},
{
"d": "2026-07-23",
"o": 17.17,
"h": 18.035,
"l": 17,
"c": 17.59,
"v": 816143.179306
},
{
"d": "2026-07-24",
"o": 17.61,
"h": 18.42,
"l": 17.22,
"c": 18.41,
"v": 1634714.293292
},
{
"d": "2026-07-27",
"o": 18.5,
"h": 19.6,
"l": 18.08,
"c": 19.49,
"v": 2581117.181396
},
{
"d": "2026-07-28",
"o": 19.79,
"h": 19.99,
"l": 18.905,
"c": 19.55,
"v": 3410856.542589
},
{
"d": "2026-07-29",
"o": 19.5,
"h": 20.21,
"l": 19.045,
"c": 19.73,
"v": 2070890.179987
},
{
"d": "2026-07-30",
"o": 19.69,
"h": 20.94,
"l": 19.31,
"c": 20.75,
"v": 3552855.15129
},
{
"d": "2026-07-31",
"o": 20.74,
"h": 20.87,
"l": 19.295,
"c": 20.31,
"v": 1832489.0259
},
{
"d": "2026-08-03",
"o": 20.29,
"h": 20.47,
"l": 19.295,
"c": 20.17,
"v": 1685578.393669
},
{
"d": "2026-08-04",
"o": 20.34,
"h": 22.28,
"l": 20.3245,
"c": 21.87,
"v": 3426238.048498
},
{
"d": "2026-08-05",
"o": 22.06,
"h": 22.1694,
"l": 21.52,
"c": 21.85,
"v": 1772235.901466
},
{
"d": "2026-08-06",
"o": 21.1,
"h": 24.36,
"l": 21.1,
"c": 24.19,
"v": 3537969.405077
},
{
"d": "2026-08-07",
"o": 24.19,
"h": 24.6,
"l": 22.56,
"c": 22.82,
"v": 2678300.051553
},
{
"d": "2026-08-10",
"o": 22.68,
"h": 23.03,
"l": 22,
"c": 22.67,
"v": 1331114.666653
},
{
"d": "2026-08-11",
"o": 22.78,
"h": 23.7299,
"l": 22.19,
"c": 23.63,
"v": 833858.876845
},
{
"d": "2026-08-12",
"o": 23.86,
"h": 24.0848,
"l": 23.3,
"c": 23.35,
"v": 1454262.251034
},
{
"d": "2026-08-13",
"o": 23.37,
"h": 23.635,
"l": 22.46,
"c": 22.48,
"v": 839453.479687
},
{
"d": "2026-08-14",
"o": 22.35,
"h": 22.39,
"l": 21.29,
"c": 21.63,
"v": 1588794.481526
},
{
"d": "2026-08-17",
"o": 21.96,
"h": 22.468,
"l": 21.28,
"c": 21.43,
"v": 1267094.531411
},
{
"d": "2026-08-18",
"o": 29.91,
"h": 35.39,
"l": 28,
"c": 35.11,
"v": 23980271.905743
},
{
"d": "2026-08-19",
"o": 36.13,
"h": 37.15,
"l": 35.3207,
"c": 35.37,
"v": 1535587.779983
}
]
}
Data:
{
"estimates": [
{
"symbol": "AMLX",
"date": "2030-12-31",
"revenueLow": 183963145,
"revenueHigh": 1548275812,
"revenueAvg": 611817333,
"ebitdaLow": 5351456,
"ebitdaHigh": 45039080,
"ebitdaAvg": 17797662,
"ebitLow": 5246330,
"ebitHigh": 44154318,
"ebitAvg": 17448039,
"netIncomeLow": 21659297,
"netIncomeHigh": 712485358,
"netIncomeAvg": 238305231,
"sgaExpenseLow": 350338610,
"sgaExpenseHigh": 2948529699,
"sgaExpenseAvg": 1165142258,
"epsAvg": 2.52,
"epsHigh": 7.5343,
"epsLow": 0.22904,
"numAnalystsRevenue": 3,
"numAnalystsEps": 1
},
{
"symbol": "AMLX",
"date": "2029-12-31",
"revenueLow": 111098554,
"revenueHigh": 935030788,
"revenueAvg": 369487167,
"ebitdaLow": 3231838,
"ebitdaHigh": 27199886,
"ebitdaAvg": 10748318,
"ebitLow": 3168350,
"ebitHigh": 26665563,
"ebitAvg": 10537175,
"netIncomeLow": 8122162,
"netIncomeHigh": 267181773,
"netIncomeAvg": 89364461,
"sgaExpenseLow": 211575601,
"sgaExpenseHigh": 1780668551,
"sgaExpenseAvg": 703649748,
"epsAvg": 0.945,
"epsHigh": 2.82536,
"epsLow": 0.08588922,
"numAnalystsRevenue": 4,
"numAnalystsEps": 1
},
{
"symbol": "AMLX",
"date": "2028-12-31",
"revenueLow": 46159353,
"revenueHigh": 322671078,
"revenueAvg": 130856540,
"ebitdaLow": 1342767,
"ebitdaHigh": 9386446,
"ebitdaAvg": 3806594,
"ebitLow": 1316389,
"ebitHigh": 9202056,
"ebitAvg": 3731816,
"netIncomeLow": -82094260,
"netIncomeHigh": -45152221,
"netIncomeAvg": -63623240.5,
"sgaExpenseLow": 87905670,
"sgaExpenseHigh": 614493392,
"sgaExpenseAvg": 249202623,
"epsAvg": -0.72488,
"epsHigh": -0.47747,
"epsLow": -0.86812,
"numAnalystsRevenue": 6,
"numAnalystsEps": 4
},
{
"symbol": "AMLX",
"date": "2027-12-31",
"revenueLow": 17873095,
"revenueHigh": 46195077,
"revenueAvg": 32043252,
"ebitdaLow": 519925,
"ebitdaHigh": 1343806,
"ebitdaAvg": 932132,
"ebitLow": 509711,
"ebitHigh": 1317408,
"ebitAvg": 913821,
"netIncomeLow": -170823242,
"netIncomeHigh": -90495465,
"netIncomeAvg": -152694380,
"sgaExpenseLow": 34037444,
"sgaExpenseHigh": 87973703,
"sgaExpenseAvg": 61023029,
"epsAvg": -1.3548,
"epsHigh": -0.95696,
"epsLow": -1.8064,
"numAnalystsRevenue": 6,
"numAnalystsEps": 6
}
],
"price_target": {
"symbol": "AMLX",
"targetHigh": 55,
"targetLow": 42,
"targetConsensus": 51.8,
"targetMedian": 55
},
"ratings": {
"symbol": "AMLX",
"rating": "C",
"overallScore": 2,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 4,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "AMLX",
"date": "2026-08-19",
"gradingCompany": "Baird",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-08-18",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-08-17",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-08-03",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-07-20",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-06-25",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-04-28",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-03-25",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-03-19",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-03-04",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-02-20",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2026-02-10",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2025-11-07",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2025-10-17",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2025-10-16",
"gradingCompany": "Baird",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2025-10-03",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2025-09-16",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2025-09-15",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "AMLX",
"date": "2025-08-28",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Guggenheim Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $55",
"url": "https://www.benzinga.com/news/26/08/61299850/guggenheim-maintains-buy-amylyx-pharmaceuticals-raises-price-target-55",
"source": "benzinga",
"date": "2026-08-19T13:31:11.103000+00:00",
"summary": "Guggenheim analyst Seamus Fernandez maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and raises the price target from $40 to $55.",
"image": ""
},
{
"title": "Baird Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $52",
"url": "https://www.benzinga.com/news/26/08/61295706/baird-maintains-outperform-amylyx-pharmaceuticals-raises-price-target-52",
"source": "benzinga",
"date": "2026-08-19T11:04:20.733000+00:00",
"summary": "Baird analyst Joel Beatty maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform and raises the price target from $28 to $52.",
"image": ""
},
{
"title": "Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast and Klarna Group: Why These 5 Stocks Are on Investors' Radars Today",
"url": "https://www.benzinga.com/news/26/08/61291426/profusa-baidu-amylyx-pharmaceuticals-freecast-and-klarna-group-why-these-5-stocks-are-on-investors-radars-today",
"source": "benzinga",
"date": "2026-08-19T01:26:58.647000+00:00",
"summary": "PFSA, BIDU, AMLX, CAST, KLAR were among the stocks seen trending on Tuesday, Aug. 18, 2026.",
"image": ""
},
{
"title": "Crude Oil Gains 1%; US Pending Home Sales Fall In July",
"url": "https://www.benzinga.com/markets/market-summary/26/08/61280050/crude-oil-gains-1-us-pending-home-sales-fall-in-july",
"source": "benzinga",
"date": "2026-08-18T16:06:45.640000+00:00",
"summary": "US stocks fell in midday trading, with S&P 500 down 0.5% and Dow dropping 0.17%. Health care shares rose 1.6%, while tech stocks fell 2.1%.",
"image": ""
},
{
"title": "Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday",
"url": "https://www.benzinga.com/news/26/08/61275092/duos-technologies-posts-upbeat-q2-results-joins-amylyx-pharmaceuticals-weave-communications-and-other-big-stocks-moving-higher-on-tuesday",
"source": "benzinga",
"date": "2026-08-18T14:11:06.929000+00:00",
"summary": "\nUS stocks down, Nasdaq falls 300+ points. Duos Tech shares rise on better Q2 results. Many other big stocks gain, including Duolingo, Intuit, and Newsmax.",
"image": ""
},
{
"title": "Why Amylyx Pharmaceuticals Stock Skyrocketed Today",
"url": "https://www.fool.com/investing/2026/08/18/why-amylyx-pharmaceuticals-stock-skyrocketed-today/",
"source": "The Motley Fool",
"date": "2026-08-18 19:10:32",
"summary": "Amylyx is developing a GLP-1 treatment for people with chronic low blood sugar. The experimental therapy displayed a favorable safety profile in a clinical study.",
"image": "https://images.financialmodelingprep.com/news/why-amylyx-pharmaceuticals-stock-skyrocketed-today-20260818.jpg"
},
{
"title": "Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock",
"url": "https://www.businesswire.com/news/home/20260818657144/en/Amylyx-Pharmaceuticals-Announces-350.0-Million-Proposed-Public-Offering-of-Common-Stock/",
"source": "Business Wire",
"date": "2026-08-18 16:01:00",
"summary": "CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (\u201cAmylyx\u201d or the \u201cCompany\u201d) today announced that it has commenced an underwritten public offering of $350.0 million of shares of its common stock. In addition, Amylyx intends to grant the und",
"image": "https://images.financialmodelingprep.com/news/amylyx-pharmaceuticals-announces-3500-million-proposed-public-offering-of-20260818.jpg"
},
{
"title": "Amylyx stock soars on GLP-1 success: here's why investors should sell",
"url": "https://invezz.com/news/2026/08/18/amylyx-stock-soars-on-glp-1-success-heres-why-investors-should-sell/",
"source": "Invezz",
"date": "2026-08-18 15:44:27",
"summary": "Amylyx Pharmaceuticals (AMLX) shares exploded to the upside on August 18th after the company reported blockbuster topline results from its pivotal Phase 3 LUCIDITY trial. The late-stage study evaluated avexitide \u2013 the pharmaceutical firm's first-in-class GLP-1 receptor antagonist",
"image": "https://images.financialmodelingprep.com/news/amylyx-stock-soars-on-glp1-success-heres-why-investors-20260818.jpg"
},
{
"title": "Amylyx Pharmaceuticals, Inc. (AMLX) Discusses Positive Phase III LUCIDITY Topline Results for Avexitide in Post-Bariatric Hypoglycemia Transcript",
"url": "https://seekingalpha.com/article/4937860-amylyx-pharmaceuticals-inc-amlx-discusses-positive-phase-iii-lucidity-topline-results-for",
"source": "Seeking Alpha",
"date": "2026-08-18 13:21:48",
"summary": "Amylyx Pharmaceuticals, Inc. (AMLX) Discusses Positive Phase III LUCIDITY Topline Results for Avexitide in Post-Bariatric Hypoglycemia Transcript",
"image": "https://images.financialmodelingprep.com/news/amylyx-pharmaceuticals-inc-amlx-discusses-positive-phase-iii-lucidity-20260818.jpg"
},
{
"title": "Amylyx: Upgraded To Strong Buy On LUCIDITY Outcome, Avexitide, And 2026 Catalysts",
"url": "https://seekingalpha.com/article/4937839-amylyx-upgraded-to-strong-buy-on-lucidity-outcome-avexitide-and-2026-catalysts",
"source": "Seeking Alpha",
"date": "2026-08-18 13:08:40",
"summary": "Amylyx Pharmaceuticals, Inc. is upgraded to Strong Buy after positive phase 3 LUCIDITY results for avexitide in post-bariatric hypoglycemia [PBH]. Avexitide met its primary endpoint, achieving a 55% reduction in severe hypoglycemic events, with strong statistical significance and",
"image": "https://images.financialmodelingprep.com/news/amylyx-upgraded-to-strong-buy-on-lucidity-outcome-avexitide-20260818.jpg"
},
{
"title": "Amylyx Phase III Avexitide Trial Cuts Severe Hypoglycemic Events 55%",
"url": "https://www.marketbeat.com/instant-alerts/amylyx-phase-iii-avexitide-trial-cuts-severe-hypoglycemic-events-55-2026-08-18/",
"source": "MarketBeat",
"date": "2026-08-18 10:04:52",
"summary": "Amylyx Pharmaceuticals NASDAQ: AMLX said its Phase III LUCIDITY trial of avexitide met its primary endpoint, reducing the composite rate of clinically significant hypoglycemic events by 55% versus placebo in adults with post-bariatric hypoglycemia following Roux-en-Y gastric bypa",
"image": "https://images.financialmodelingprep.com/news/amylyx-phase-iii-avexitide-trial-cuts-severe-hypoglycemic-events-20260818.jpg"
},
{
"title": "Amylyx Pharmaceuticals Comes Closer to Potentially Delivering First Treatment for Weight Loss Surgery-Related Low Suger Level",
"url": "https://www.benzinga.com/news/health-care/26/08/61272791/amylyx-pharmaceuticals-comes-closer-to-potentially-delivering-first-treatment-for-weight-loss-surgery-related-low-suger-level",
"source": "Benzinga",
"date": "2026-08-18 09:26:57",
"summary": "Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) stock is trading higher on Tuesday after the company released highly favorable topline data from its Phase 3 LUCIDITY clinical trial.",
"image": "https://images.financialmodelingprep.com/news/amylyx-pharmaceuticals-comes-closer-to-potentially-delivering-first-treatment-20260818.jpg"
},
{
"title": "Amylyx Stock Surges 21% After GLP-1 Drug Succeeds in Phase 3 Trial",
"url": "https://www.barrons.com/articles/amylyx-stock-glp-1-drug-trial-439b920b",
"source": "Barrons",
"date": "2026-08-18 07:23:00",
"summary": "Amylyx Pharmaceuticals says its GLP-1 receptor antagonist, avexitide, met both the primary and secondary endpoints in a late-stage clinical trial.",
"image": "https://images.financialmodelingprep.com/news/amylyx-stock-surges-21-after-glp1-drug-succeeds-in-20260818.jpg"
},
{
"title": "Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial",
"url": "https://www.reuters.com/business/healthcare-pharmaceuticals/amylyx-drug-cuts-low-blood-sugar-episodes-bariatric-surgery-patients-key-trial-2026-08-18/",
"source": "Reuters",
"date": "2026-08-18 07:14:22",
"summary": "Amylyx Pharmaceuticals said on Tuesday its experimental drug met its main goal in a late-stage trial for post-bariatric \u200bhypoglycemia, a condition marked by dangerously low blood sugar \u200clevels following weight-loss surgery.",
"image": "https://images.financialmodelingprep.com/news/amylyx-drug-cuts-low-blood-sugar-episodes-in-bariatric-20260818.jpg"
},
{
"title": "Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia",
"url": "https://www.businesswire.com/news/home/20260817275387/en/Amylyx-Pharmaceuticals-Announces-Positive-Topline-Results-from-Phase-3-LUCIDITY-Clinical-Trial-of-Avexitide-in-Post-Bariatric-Hypoglycemia/",
"source": "Business Wire",
"date": "2026-08-18 07:00:00",
"summary": "CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (\u201cAmylyx\u201d or the \u201cCompany\u201d) today announced positive topline results from LUCIDITY, a 78-participant, multicenter, randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluati",
"image": "https://images.financialmodelingprep.com/news/amylyx-pharmaceuticals-announces-positive-topline-results-from-phase-3-20260818.jpg"
},
{
"title": "Amylyx Pharmaceuticals Stock Soars After the Close: Here's Why",
"url": "https://www.benzinga.com/trading-ideas/movers/26/08/61261799/amylyx-pharmaceuticals-stock-soars-after-the-close-heres-why",
"source": "Benzinga",
"date": "2026-08-17 16:53:03",
"summary": "Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) shares are trading higher in Monday's after-hours session after the company scheduled a Phase 3 trial results readout for this week.",
"image": "https://images.financialmodelingprep.com/news/amylyx-pharmaceuticals-stock-soars-after-the-close-heres-why-20260817.jpg"
},
{
"title": "Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026",
"url": "https://www.businesswire.com/news/home/20260817660841/en/Amylyx-Pharmaceuticals-to-Announce-Topline-Results-from-its-Phase-3-LUCIDITY-Clinical-Trial-of-Avexitide-in-Post-Bariatric-Hypoglycemia-on-August-18-2026/",
"source": "Business Wire",
"date": "2026-08-17 16:01:00",
"summary": "CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (\u201cAmylyx\u201d or the \u201cCompany\u201d) will announce topline results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026. Amylyx's senior management t",
"image": "https://images.financialmodelingprep.com/news/amylyx-pharmaceuticals-to-announce-topline-results-from-its-phase-20260817.jpg"
},
{
"title": "4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year",
"url": "https://www.zacks.com/stock/news/2972765/4-biotech-stocks-with-major-second-half-pipeline-catalysts-this-year?cid=CS-STOCKNEWSAPI-FT-analyst_blog|investment_ideas-2972765",
"source": "Zacks Investment Research",
"date": "2026-08-11 11:05:38",
"summary": "Vertex Pharmaceuticals, Amylyx Pharmaceuticals, Praxis Precision Medicines and BridgeBio Pharma face major 2026 catalysts, from FDA decisions to late-stage readouts.",
"image": "https://images.financialmodelingprep.com/news/4-biotech-stocks-with-major-secondhalf-pipeline-catalysts-this-20260811.jpg"
},
{
"title": "Amylyx Pharmaceuticals, Inc. $AMLX Shares Bought by Bank of New York Mellon Corp",
"url": "https://www.defenseworld.net/2026/08/08/amylyx-pharmaceuticals-inc-amlx-shares-bought-by-bank-of-new-york-mellon-corp.html",
"source": "Defense World",
"date": "2026-08-08 03:54:56",
"summary": "Bank of New York Mellon Corp raised its stake in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) by 15.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 251,104 shares of the company's stock after bu",
"image": "https://images.financialmodelingprep.com/news/amylyx-pharmaceuticals-inc-amlx-shares-bought-by-bank-of-20260808.png"
},
{
"title": "Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild",
"url": "https://seekingalpha.com/article/4933147-amylyx-pharmaceuticals-avexitide-defines-the-endocrine-rebuild",
"source": "Seeking Alpha",
"date": "2026-08-07 11:28:15",
"summary": "Amylyx Pharmaceuticals (AMLX) is transitioning from its ALS legacy to a late-stage endocrine company, with avexitide as its lead asset. AMLX's $250.8M cash runway extends into 2028, supporting LUCIDITY Phase 3 readout, regulatory submission, and potential 2027 launch without near",
"image": "https://images.financialmodelingprep.com/news/amylyx-pharmaceuticals-avexitide-defines-the-endocrine-rebuild-20260807.jpg"
},
{
"title": "Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
"url": "https://www.globenewswire.com/news-release/2026/02/19/3240807/0/en/Global-Amyotrophic-Lateral-Sclerosis-Therapeutics-Market-Size-Share-Worth-USD-1964-Million-by-2035-at-11-5-CAGR-Custom-Market-Insights-Analysis-Outlook-Leaders-Report-Trends-Foreca.html",
"source": "GlobeNewswire Inc.",
"date": "2026-02-19T08:30:00Z",
"summary": "The global ALS therapeutics market is valued at USD 812 million in 2024 and is projected to reach USD 1,964 million by 2035, growing at an 11.5% CAGR. Growth is driven by innovations in genetic therapies, gene-silencing technologies, improved diagnostics, and increased disease aw",
"image": "https://ml.globenewswire.com/Resource/Download/74609d89-5437-4826-b7b8-31238ea2e65c"
},
{
"title": "Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2025/08/28/3141021/0/en/Antisense-Oligonucleotide-Therapeutics-Clinical-Trial-Pipeline-Appears-Robust-With-70-Key-Pharma-Companies-Actively-Working-in-the-Domain-DelveInsight.html",
"source": "GlobeNewswire Inc.",
"date": "2025-08-28T17:00:00Z",
"summary": "Antisense oligonucleotide (ASO) therapeutics are emerging as a promising treatment approach for rare genetic and neuromuscular disorders, with over 70 pharmaceutical companies actively developing 90+ pipeline therapeutics targeting specific genetic mechanisms.",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
}
]
Data:
[
{
"symbol": "AMLX",
"date": "2026-11-05",
"epsActual": null,
"epsEstimated": -0.38,
"revenueActual": null,
"revenueEstimated": 59429,
"lastUpdated": "2026-08-19"
},
{
"symbol": "AMLX",
"date": "2026-08-06",
"epsActual": -0.39,
"epsEstimated": -0.3609,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-08-19"
},
{
"symbol": "AMLX",
"date": "2026-05-07",
"epsActual": -0.37,
"epsEstimated": -0.34,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-08-07"
},
{
"symbol": "AMLX",
"date": "2026-03-03",
"epsActual": -0.3,
"epsEstimated": -0.31,
"revenueActual": null,
"revenueEstimated": -52000,
"lastUpdated": "2026-06-03"
},
{
"symbol": "AMLX",
"date": "2025-11-06",
"epsActual": -0.37,
"epsEstimated": -0.43,
"revenueActual": null,
"revenueEstimated": 52000,
"lastUpdated": "2026-02-04"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "AMLX",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "AMLX",
"periods": [
{
"file_period": "202604a",
"settlement_date": "20260414",
"quantity_fails": 173,
"price": 16.47
},
{
"file_period": "202604b",
"settlement_date": "20260430",
"quantity_fails": 347,
"price": 15.6
},
{
"file_period": "202606a",
"settlement_date": "20260604",
"quantity_fails": 3,
"price": 13.2
},
{
"file_period": "202606b",
"settlement_date": "20260622",
"quantity_fails": 13556,
"price": 15.67
},
{
"file_period": "202607a",
"settlement_date": "20260714",
"quantity_fails": 140,
"price": 17.41
},
{
"file_period": "202607b",
"settlement_date": "20260728",
"quantity_fails": 21,
"price": 19.49
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "AMLX",
"filingDate": "2026-07-13",
"transactionDate": "2026-07-09",
"reportingCik": "0001913765",
"companyCik": "0001658551",
"transactionType": "S-Sale",
"securitiesOwned": 194090,
"reportingName": "Mazzariello Gina",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 15000,
"price": 18.3164,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526301996/0001193125-26-301996-index.htm"
},
{
"symbol": "AMLX",
"filingDate": "2026-07-13",
"transactionDate": "2026-07-10",
"reportingCik": "0001913765",
"companyCik": "0001658551",
"transactionType": "S-Sale",
"securitiesOwned": 179090,
"reportingName": "Mazzariello Gina",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 15000,
"price": 17.6081,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526301996/0001193125-26-301996-index.htm"
},
{
"symbol": "AMLX",
"filingDate": "2026-06-08",
"transactionDate": "2026-06-04",
"reportingCik": "0001971421",
"companyCik": "0001658551",
"transactionType": "A-Award",
"securitiesOwned": 24372,
"reportingName": "Zeiher Bernhardt G",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 24372,
"price": 14.31,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526261647/0001193125-26-261647-index.htm"
},
{
"symbol": "AMLX",
"filingDate": "2026-06-08",
"transactionDate": "2026-06-04",
"reportingCik": "0001969821",
"companyCik": "0001658551",
"transactionType": "A-Award",
"securitiesOwned": 24372,
"reportingName": "Firestone Karen",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 24372,
"price": 14.31,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526261641/0001193125-26-261641-index.htm"
},
{
"symbol": "AMLX",
"filingDate": "2026-06-08",
"transactionDate": "2026-06-04",
"reportingCik": "0001543031",
"companyCik": "0001658551",
"transactionType": "A-Award",
"securitiesOwned": 24372,
"reportingName": "Quimi Daphne",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 24372,
"price": 14.31,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526261640/0001193125-26-261640-index.htm"
},
{
"symbol": "AMLX",
"filingDate": "2026-06-08",
"transactionDate": "2026-06-04",
"reportingCik": "0001179552",
"companyCik": "0001658551",
"transactionType": "A-Award",
"securitiesOwned": 24372,
"reportingName": "MILNE GEORGE M JR",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 24372,
"price": 14.31,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526261638/0001193125-26-261638-index.htm"
},
{
"symbol": "AMLX",
"filingDate": "2026-06-08",
"transactionDate": "2026-06-04",
"reportingCik": "0001727550",
"companyCik": "0001658551",
"transactionType": "A-Award",
"securitiesOwned": 24372,
"reportingName": "FONTEYNE PAUL R.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 24372,
"price": 14.31,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526261637/0001193125-26-261637-index.htm"
},
{
"symbol": "AMLX",
"filingDate": "2026-05-26",
"transactionDate": "2026-05-21",
"reportingCik": "0001969821",
"companyCik": "0001658551",
"transactionType": "P-Purchase",
"securitiesOwned": 66900,
"reportingName": "Firestone Karen",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3800,
"price": 13.51,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526239216/0001193125-26-239216-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "AMLX",
"senateID": "",
"disclosureDate": "2022-11-16",
"transactionDate": "2022-10-12",
"firstName": "Christopher L.",
"lastName": "Jacobs",
"office": "Christopher L. Jacobs",
"district": "NY27",
"owner": "",
"assetDescription": "Amylyx Pharmaceuticals, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20021989.pdf"
}
],
"dark_pool": [
{
"ticker": "AMLX",
"executed_at": "2026-08-19T13:49:01.161000Z",
"size": 1000.0,
"price": 35.7,
"premium": 35700.0,
"volume": 1000.0,
"trade_code": " "
},
{
"ticker": "AMLX",
"executed_at": "2026-08-19T13:48:47.464000Z",
"size": 1000.0,
"price": 35.6999,
"premium": 35699.9,
"volume": 1000.0,
"trade_code": " "
},
{
"ticker": "AMLX",
"executed_at": "2026-08-19T13:48:36.846000Z",
"size": 666.0,
"price": 35.7,
"premium": 23776.2,
"volume": 666.0,
"trade_code": " "
},
{
"ticker": "AMLX",
"executed_at": "2026-08-19T13:49:03.290000Z",
"size": 500.0,
"price": 35.7001,
"premium": 17850.05,
"volume": 500.0,
"trade_code": " "
},
{
"ticker": "AMLX",
"executed_at": "2026-08-19T13:48:53.183000Z",
"size": 219.0,
"price": 35.68,
"premium": 7813.92,
"volume": 219.0,
"trade_code": " "
},
{
"ticker": "AMLX",
"executed_at": "2026-08-19T13:49:01.191000Z",
"size": 200.0,
"price": 35.7,
"premium": 7140.000000000001,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "AMLX",
"executed_at": "2026-08-19T13:49:01.188000Z",
"size": 200.0,
"price": 35.7,
"premium": 7140.000000000001,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "AMLX",
"executed_at": "2026-08-19T13:49:01.187000Z",
"size": 200.0,
"price": 35.7,
"premium": 7140.000000000001,
"volume": 200.0,
"trade_code": "F"
}
],
"ats": {
"symbol": "AMLX",
"date": "20260818",
"ats_volume": 0,
"total_volume": 10212316,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260818",
"ats_ratio": 0.0
},
{
"date": "20260817",
"ats_ratio": 0.0
},
{
"date": "20260814",
"ats_ratio": 0.0
},
{
"date": "20260813",
"ats_ratio": 0.0
},
{
"date": "20260812",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "AMLX",
"days": [
{
"date": "2026-08-19",
"close": 35.7,
"vwap": 36.28,
"volume": 1556739,
"vwap_discount_pct": 1.62
},
{
"date": "2026-08-18",
"close": 35.11,
"vwap": 31.44,
"volume": 23980271,
"vwap_discount_pct": -10.44
},
{
"date": "2026-08-17",
"close": 21.43,
"vwap": 22.37,
"volume": 1267094,
"vwap_discount_pct": 4.38
},
{
"date": "2026-08-14",
"close": 21.63,
"vwap": 21.63,
"volume": 1588794,
"vwap_discount_pct": -0.01
},
{
"date": "2026-08-13",
"close": 22.48,
"vwap": 22.85,
"volume": 839453,
"vwap_discount_pct": 1.65
}
],
"avg_vwap_discount_pct": -0.56,
"signal": "Distribution"
},
"options_flow": [],
"net_premium": {
"ticker": "AMLX",
"net_call_premium": "8870.00",
"net_put_premium": "-24858.00",
"call_premium": "114906.00",
"put_premium": "37601.00",
"bullish_premium": "87010.00",
"bearish_premium": "53282.00",
"put_call_ratio": "0.44198174706649282920",
"iv_rank": "17.3079",
"implied_move_perc": "0.125000",
"gex_ratio": "0.22478997052605417218",
"gex_net_change": "-18437.7933",
"gex_call": "81700.6998",
"gex_put": "-18365.4979",
"gex_net": 63335.2019,
"gex_call_delta": "2453153.3082",
"gex_put_delta": "-118553.4411",
"gex_date": "2026-08-19"
},
"hot_chains": [
{
"underlying_symbol": "AMLX",
"expires": "2026-08-21",
"open_interest": 945,
"option_type": "call",
"delta": 0.1217999355045012,
"ask_volume": 215,
"last_price": "0.25",
"implied_volatility": "1.358134898704349",
"gamma": 0.0594586935184039,
"avg_price": "0.3987311827956989247311827960",
"bid_volume": 250,
"nbbo_ask": "0.35",
"strike": "40",
"option_symbol": "AMLX260821C00040000",
"total_premium": "18541.00",
"iv": 1.213363983479627,
"volume": 465,
"nbbo_bid": "0.20"
},
{
"underlying_symbol": "AMLX",
"expires": "2026-08-21",
"open_interest": 845,
"option_type": "call",
"delta": 0.594733025046693,
"ask_volume": 44,
"last_price": "1.60",
"implied_volatility": "1.145094988412976",
"gamma": 0.1193614550257217,
"avg_price": "2.0255357142857142857142857143",
"bid_volume": 44,
"nbbo_ask": "1.95",
"strike": "35",
"option_symbol": "AMLX260821C00035000",
"total_premium": "22686.00",
"iv": 1.159055244434348,
"volume": 112,
"nbbo_bid": "1.40"
},
{
"underlying_symbol": "AMLX",
"expires": "2026-09-18",
"open_interest": 418,
"option_type": "put",
"delta": -0.0678953353283385,
"ask_volume": 5,
"last_price": "0.23",
"implied_volatility": "0.870780829228452",
"gamma": 0.01415243004911861,
"avg_price": "0.2490476190476190476190476190",
"bid_volume": 100,
"nbbo_ask": "0.45",
"strike": "25",
"option_symbol": "AMLX260918P00025000",
"total_premium": "2615.00",
"iv": 0.903428204856771,
"volume": 105,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "AMLX",
"expires": "2026-09-18",
"open_interest": 157,
"option_type": "put",
"delta": -0.425035144437801,
"ask_volume": 9,
"last_price": "2.30",
"implied_volatility": "0.674927117204305",
"gamma": 0.0644077091961404,
"avg_price": "2.6781818181818181818181818183",
"bid_volume": 46,
"nbbo_ask": "2.70",
"strike": "35",
"option_symbol": "AMLX260918P00035000",
"total_premium": "14730.00",
"iv": 0.593178294013646,
"volume": 55,
"nbbo_bid": "2.00"
},
{
"underlying_symbol": "AMLX",
"expires": "2026-08-21",
"open_interest": 0,
"option_type": "put",
"delta": -0.520062747639309,
"ask_volume": 1,
"last_price": "1.90",
"implied_volatility": "1.907380243850332",
"gamma": 0.108689553139999,
"avg_price": "1.4888000000000000000000000001",
"bid_volume": 47,
"nbbo_ask": "1.85",
"strike": "36",
"option_symbol": "AMLX260821P00036000",
"total_premium": "7444.00",
"iv": 1.308311334103406,
"volume": 50,
"nbbo_bid": "0.90"
},
{
"underlying_symbol": "AMLX",
"expires": "2026-09-18",
"open_interest": 0,
"option_type": "call",
"delta": 0.517123716595149,
"ask_volume": 50,
"last_price": "3.53",
"implied_volatility": "0.710435595804853",
"gamma": 0.057704146658871,
"avg_price": "3.8308000000000000000000000000",
"bid_volume": 0,
"nbbo_ask": "3.90",
"strike": "36",
"option_symbol": "AMLX260918C00036000",
"total_premium": "19154.00",
"iv": 0.673402688501506,
"volume": 50,
"nbbo_bid": "3.00"
},
{
"underlying_symbol": "AMLX",
"expires": "2026-08-21",
"open_interest": 83,
"option_type": "put",
"delta": -0.1386382085715896,
"ask_volume": 0,
"last_price": "0.20",
"implied_volatility": "1.350102833659041",
"gamma": 0.0598356856583369,
"avg_price": "0.2365384615384615384615384615",
"bid_volume": 26,
"nbbo_ask": "0.20",
"strike": "32",
"option_symbol": "AMLX260821P00032000",
"total_premium": "615.00",
"iv": 1.318771756426804,
"volume": 26,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "AMLX",
"expires": "2026-09-18",
"open_interest": 3713,
"option_type": "call",
"delta": 0.574656083148993,
"ask_volume": 7,
"last_price": "3.00",
"implied_volatility": "0.667979188307963",
"gamma": 0.0566524677347445,
"avg_price": "3.3926923076923076923076923077",
"bid_volume": 12,
"nbbo_ask": "3.20",
"strike": "35",
"option_symbol": "AMLX260918C00035000",
"total_premium": "8821.00",
"iv": 0.674479595934725,
"volume": 26,
"nbbo_bid": "2.85"
}
],
"gamma_profile": {
"ticker": "AMLX",
"spot": 35.73,
"date": "2026-08-19",
"flip_point": 34.16,
"net_gex": 63335.2,
"call_walls": [
{
"strike": 40.0,
"gex": 35727.58
},
{
"strike": 35.0,
"gex": 34840.57
},
{
"strike": 30.0,
"gex": 5441.58
}
],
"put_walls": [
{
"strike": 30.0,
"gex": -5817.99
},
{
"strike": 21.0,
"gex": -2366.11
},
{
"strike": 17.0,
"gex": -1914.35
}
],
"by_strike": [
{
"strike": 24.0,
"call_gex": 0.02,
"put_gex": -3.6,
"net_gex": -3.58
},
{
"strike": 25.0,
"call_gex": 2869.92,
"put_gex": -1034.05,
"net_gex": 1835.86
},
{
"strike": 26.0,
"call_gex": 0.53,
"put_gex": -95.27,
"net_gex": -94.74
},
{
"strike": 27.0,
"call_gex": 808.98,
"put_gex": -462.34,
"net_gex": 346.64
},
{
"strike": 28.0,
"call_gex": 0.0,
"put_gex": -39.8,
"net_gex": -39.8
},
{
"strike": 29.0,
"call_gex": 0.0,
"put_gex": -77.17,
"net_gex": -77.17
},
{
"strike": 30.0,
"call_gex": 5441.58,
"put_gex": -5817.99,
"net_gex": -376.42
},
{
"strike": 31.0,
"call_gex": 0.08,
"put_gex": -346.59,
"net_gex": -346.51
},
{
"strike": 32.0,
"call_gex": 133.96,
"put_gex": -381.63,
"net_gex": -247.68
},
{
"strike": 33.0,
"call_gex": 15.64,
"put_gex": -1406.24,
"net_gex": -1390.6
},
{
"strike": 34.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 35.0,
"call_gex": 34840.57,
"put_gex": -1717.57,
"net_gex": 33123.0
},
{
"strike": 36.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 37.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 38.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 39.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 40.0,
"call_gex": 35727.58,
"put_gex": -264.79,
"net_gex": 35462.79
},
{
"strike": 41.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 42.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 43.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 44.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 45.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 46.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 47.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 48.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
}
]
},
"oi_changes": {
"net_call_oi_change": -6346,
"net_put_oi_change": -111,
"top": [
{
"strike": "35",
"oi_change": -5647,
"type": "call"
},
{
"strike": "20",
"oi_change": -854,
"type": "call"
},
{
"strike": "40",
"oi_change": 160,
"type": "call"
},
{
"strike": "17",
"oi_change": -42,
"type": "put"
},
{
"strike": "12",
"oi_change": -40,
"type": "put"
}
]
}
}
Data:
{
"vix": 14.25,
"sp500": 7785.76,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.51,
"hy_spread": 2.71,
"treasury": {
"date": "2026-08-17",
"month1": 3.79,
"month2": 3.82,
"month3": 3.87,
"month6": 3.95,
"year1": 4,
"year2": 4.19,
"year3": 4.25,
"year5": 4.38,
"year7": 4.54,
"year10": 4.72,
"year20": 5.3,
"year30": 5.31
},
"events": [
{
"title": "FOMC Meeting Minutes",
"currency": "USD",
"date": "2026-08-19",
"time_utc": "18:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": 266
}
]
}
Data:
{
"days": 45,
"patterns": [
{
"name": "VWAP Touch",
"count": 45,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 45,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 45,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 42,
"pct": 93
},
{
"name": "Woodie Pivot Touch",
"count": 41,
"pct": 91
},
{
"name": "PDH/PDL Touch",
"count": 37,
"pct": 82
},
{
"name": "Gap Fill",
"count": 33,
"pct": 73
},
{
"name": "Open Retracement",
"count": 30,
"pct": 67
},
{
"name": "Power Hour",
"count": 11,
"pct": 24
},
{
"name": "High Vol Open",
"count": 11,
"pct": 24
},
{
"name": "Darvas Box",
"count": 11,
"pct": 24
}
]
}